INSP
Income statement / Annual
Last year (2023), Inspire Medical Systems, Inc.'s total revenue was $624.80 M,
an increase of 53.19% from the previous year.
In 2023, Inspire Medical Systems, Inc.'s net income was -$21.15 M.
See Inspire Medical Systems, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$624.80 M
|
$407.86 M
|
$233.39 M
|
$115.38 M
|
$82.05 M
|
$50.59 M
|
$28.57 M
|
$16.43 M
|
$8.01 M
|
| Cost of Revenue |
$96.58 M |
$66.12 M |
$33.28 M |
$17.62 M |
$13.64 M |
$10.06 M |
$6.02 M |
$3.91 M |
$2.81 M |
| Gross Profit |
$528.22 M |
$341.74 M |
$200.12 M |
$97.76 M |
$68.41 M |
$40.54 M |
$22.55 M |
$12.52 M |
$5.20 M |
| Gross Profit Ratio |
0.85 |
0.84 |
0.86 |
0.85 |
0.83 |
0.8 |
0.79 |
0.76 |
0.65 |
| Research and Development
Expenses |
$116.54 M
|
$68.65 M
|
$37.35 M
|
$26.09 M
|
$12.84 M
|
$7.39 M
|
$6.19 M
|
$7.09 M
|
$7.08 M
|
| General & Administrative
Expenses |
$351.66 M
|
$246.39 M
|
$154.82 M
|
$101.47 M
|
$72.47 M
|
$53.53 M
|
$3.81 M
|
$19.28 M
|
$2.63 M
|
| Selling & Marketing
Expenses |
$100.30 M
|
$74.30 M
|
$47.80 M
|
$26.40 M
|
$18.00 M
|
$9.30 M
|
$28.55 M
|
$3.40 M
|
$15.29 M
|
| Selling, General &
Administrative Expenses |
$451.96 M
|
$320.69 M
|
$202.62 M
|
$127.87 M
|
$90.47 M
|
$53.53 M
|
$32.36 M
|
$22.68 M
|
$17.92 M
|
| Other Expenses |
$0.00 |
-$49,000.00 |
-$117,000.00 |
$145,000.00 |
$12,000.00 |
-$16,000.00 |
$42,000.00 |
-$29,000.00 |
-$41,000.00 |
| Operating Expenses |
$568.49 M |
$389.33 M |
$239.97 M |
$153.97 M |
$103.30 M |
$60.92 M |
$38.55 M |
$29.78 M |
$25.00 M |
| Cost And Expenses |
$665.07 M |
$455.45 M |
$273.24 M |
$171.59 M |
$116.95 M |
$70.97 M |
$44.57 M |
$33.68 M |
$27.81 M |
| Interest Income |
$20.56 M |
$5.05 M |
$125,000.00 |
$1.09 M |
$3.80 M |
$1.87 M |
$203,000.00 |
$57,000.00 |
$66,000.00 |
| Interest Expense |
$0.00 |
$1.68 M |
$2.13 M |
$2.12 M |
$2.12 M |
$3.30 M |
$1.75 M |
$1.30 M |
$1.56 M |
| Depreciation &
Amortization |
$2.85 M
|
$2.90 M
|
$1.99 M
|
$1.81 M
|
$1.40 M
|
$393,000.00
|
$285,000.00
|
$103,000.00
|
$120,000.00
|
| EBITDA |
-$17.06 M
|
-$39.69 M
|
-$38.62 M
|
-$53.16 M
|
-$29.69 M
|
-$18.13 M
|
-$15.47 M
|
-$17.12 M
|
-$19.65 M
|
| EBITDA Ratio |
-0.03 |
-0.1 |
-0.17 |
-0.48 |
-0.38 |
-0.37 |
-0.54 |
-1.04 |
-2.45 |
| Operating Income Ratio
|
-0.06
|
-0.12
|
-0.17
|
-0.49
|
-0.43
|
-0.4
|
-0.56
|
-1.05
|
-2.47
|
| Total Other
Income/Expenses Net |
$20.37 M
|
$3.32 M
|
-$2.12 M
|
-$880,000.00
|
$1.69 M
|
-$1.45 M
|
-$1.51 M
|
-$1.28 M
|
-$1.54 M
|
| Income Before Tax |
-$19.91 M |
-$44.27 M |
-$41.97 M |
-$57.09 M |
-$33.20 M |
-$21.83 M |
-$17.51 M |
-$18.53 M |
-$21.34 M |
| Income Before Tax Ratio
|
-0.03
|
-0.11
|
-0.18
|
-0.49
|
-0.4
|
-0.43
|
-0.61
|
-1.13
|
-2.66
|
| Income Tax Expense |
$1.25 M |
$613,000.00 |
$72,000.00 |
$115,000.00 |
$40,000.00 |
$1.85 M |
$1.80 M |
$1.27 M |
$1.52 M |
| Net Income |
-$21.15 M |
-$44.88 M |
-$42.04 M |
-$57.20 M |
-$33.24 M |
-$21.83 M |
-$17.51 M |
-$18.53 M |
-$21.34 M |
| Net Income Ratio |
-0.03 |
-0.11 |
-0.18 |
-0.5 |
-0.41 |
-0.43 |
-0.61 |
-1.13 |
-2.66 |
| EPS |
-0.72 |
-1.6 |
-1.54 |
-2.19 |
-1.4 |
-1.5 |
-1.3 |
-1.49 |
-1.71 |
| EPS Diluted |
-0.72 |
-1.6 |
-1.54 |
-2.19 |
-1.4 |
-1.5 |
-1.3 |
-1.49 |
-1.71 |
| Weighted Average Shares
Out |
$29.30 M
|
$28.07 M
|
$27.26 M
|
$26.07 M
|
$23.80 M
|
$14.58 M
|
$13.49 M
|
$12.46 M
|
$12.46 M
|
| Weighted Average Shares
Out Diluted |
$29.30 M
|
$28.07 M
|
$27.26 M
|
$26.07 M
|
$23.80 M
|
$14.58 M
|
$13.49 M
|
$12.46 M
|
$12.46 M
|
| Link |
|
|
|
|
|
|
|
|
|
